The Monoclonal Antibodies Market is witnessing significant growth, driven by the rising demand for targeted therapies in the treatment of chronic diseases, including cancer, autoimmune disorders, and infectious diseases. Monoclonal antibodies (mAbs) are laboratory-produced molecules that mimic the immune system's ability to fight pathogens and are a cornerstone of biological drug development....
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek